Gilead files first hepatitis delta therapy with FDAGilead Sciences has submitted its marketing application for bulevirtide, its antiviral therapy for rare hepatitis delta virus (HDV) Share XGilead files first hepatitis delta therapy with FDAhttps://pharmaphorum.com/news/gilead-files-first-hepatitis-delta-therapy-with-fda/
